Results 31 to 40 of about 301,296 (304)

Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1_(2) - Venous Thromboembolism in Neurocritical Care Patients

open access: yes, 2019
Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1_(2) for Venous Thromboembolism in Neurocritical Care Patients by Tanuwong Viarasilpa, Nicha Panyavachiraporn, Jack Jordan, Seyed Mani Marashi, Meredith van Harn, Noel O ...
Jack Jordan (6679748)   +7 more
core   +1 more source

Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER) [PDF]

open access: yes, 2010
Venous thromboembolism (VTE) prophylaxis remains underutilized, particularly in cancer patients. We explored clinical predictors of prophylaxis in hospitalized cancer patients before the onset of acute ...
Korte, W   +16 more
core   +2 more sources

Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1 - Venous Thromboembolism in Neurocritical Care Patients

open access: yes, 2019
Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1 for Venous Thromboembolism in Neurocritical Care Patients by Tanuwong Viarasilpa, Nicha Panyavachiraporn, Jack Jordan, Seyed Mani Marashi, Meredith van Harn, Noel O ...
Jack Jordan (6679748)   +7 more
core   +1 more source

Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation

open access: yesHaematologica, 2012
Background Studies evaluating risk factors for in-hospital venous thromboembolism in children are limited by quality assurance of case definition and/or lack of controlled comparison.
Brian R. Branchford   +5 more
doaj   +1 more source

THALASSEMIA AND VENOUS THROMBOEMBOLISM

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2011
Although the life expectancy of thalassemia patients has markedly improved over the last few decades, patients still suffer from many complications of this congenital disease. The presence of a high incidence of thromboembolic events, mainly in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients.
Khaled M. Musallam   +2 more
openaire   +5 more sources

Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study

open access: yesThrombosis Journal, 2020
Background The role of venous obstructions as a risk factor for recurrent venous thromboembolism has never been evaluated. This study aimed to determine whether there is a difference in prevalence of venous obstructions between patients with and without ...
Pascale Notten   +4 more
doaj   +1 more source

Simple measures can improve care in our hospitals : an audit of venous thromboembolism practice [PDF]

open access: yes, 2013
: Venous thromboembolism (VTE) is a serious but preventable complication of hospitalisation. Doctors still sometimes fail to adhere to them, thus putting patients at risk and incurring considerable expense for the national health service.
Azzopardi, Stephanie   +3 more
core  

Diffuse MRI Edema Predicts Relapse in Cerebral Amyloid Angiopathy–Related Inflammation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To identify MRI predictors of relapse and quantify relapse and mortality risk in cerebral amyloid angiopathy–related inflammation (CAA‐RI). A secondary objective was to assess the association between mycophenolate mofetil use and relapse risk. Methods We performed a retrospective cohort study of 36 patients with CAA‐RI treated at the
G. Abbas Kharal   +10 more
wiley   +1 more source

Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism [PDF]

open access: yes, 2019
Venous thromboembolism is a frequent complication in patients with cancer. Homozygous carriers of the fibrinogen gamma gene (FGG) rs2066865 have a moderately increased risk of venous thromboembolism, but the effect of the FGG variant in cancer is unknown.
Frazer, Kelly A   +35 more
core   +1 more source

Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate treatment effect heterogeneity across phenotypic clusters of patients with cryptogenic embolic stroke using causal inference methods. Methods From a retrospective, multicenter cohort of patients with cryptogenic embolic stroke, we estimated the treatment effect of anticoagulation versus antiplatelet therapy in patients ...
Elena Badillo Goicoechea   +53 more
wiley   +1 more source

Home - About - Disclaimer - Privacy